Viewing Study NCT03177460


Ignite Creation Date: 2025-12-25 @ 2:03 AM
Ignite Modification Date: 2026-04-21 @ 8:15 PM
Study NCT ID: NCT03177460
Status: COMPLETED
Last Update Posted: 2024-05-03
First Post: 2017-06-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Daratumumab or FMS Inhibitor JNJ-40346527 Before Surgery in Treating Patients With High-Risk, Resectable Localized or Locally Advanced Prostate Cancer
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module